Modular Medical
Private Company
Funding information not available
Overview
Modular Medical is a development-stage medical device company creating a simplified insulin pump, the MODD1, aimed at the large population of insulin-dependent diabetics who find current pump technology overwhelming. The company leverages disruptive micro-pumping technology and a founder with a proven track record in diabetes device innovation, including the founding of Tandem Diabetes Care. Its strategy targets a significant market opportunity by offering a device that facilitates easier transition from injections, potentially improving adherence and health outcomes. As a publicly traded company, it is currently in the pre-revenue, pre-commercial stage, advancing the MODD1 towards regulatory clearance and market launch.
Technology Platform
Disruptive micro-pumping technology integrated into a simplified, user-friendly insulin pump (MODD1) designed for easy transition from multiple daily injections, with data sharing capabilities.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Modular Medical competes in the insulin pump market dominated by large, well-funded players like Medtronic, Insulet (Omnipod), and Tandem Diabetes Care, which offer advanced, connected systems with automated features. Its differentiation is a deliberate focus on simplicity and ease of use, rather than competing on advanced technological features, aiming to capture users who find existing options overwhelming.